Home   About the Journal  Editorial Board  Online Journal   Publishing Ethics   Contact Us  Chinese Version
You are here:Home => Online Journal => 7期肝癌的诊断和治疗 => 专家论坛 =>
Clinical predictive models for individualized treatment of hepatocellular carcinoma
文章发布日期:2018年06月07日  来源:  作者:王葵,邹奇飞,沈锋,等  点击次数:912次  下载次数:126次
Adjust font size:Small regular big

【Abstract】:Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China and has high incidence and mortality rates. HCC is often accompanied by hepatitis and liver cirrhosis, and therefore, there is high demand for precise treatment based on disease stage, tumor location, and liver function. Various diagnostic and treatment methods used in clinical practice have a certain therapeutic effect on HCC, and the issue of effective prognostic analysis and selection of individualized treatment regimen needs to be solved urgently. There are many predictive systems for the prognosis of HCC, among which nomogram can better help with the individualized analysis of HCC patients and has thus attracted more and more attention. At present, various nomographic predictive models have been established for different types of HCC; such models integrate some clinical and pathological indices, such as tumor markers, liver function, HBV indices, and microvascular tumor thrombus, and then risk score is calculated for each patient to predict prognosis. Meanwhile, clinicians can select the appropriate therapeutic method and postoperative anti-recurrence treatment based on the level of risk to achieve the goal of individualized treatment.
【Key words】:carcinoma, hepatocellular; nomograms; therapy, computer-assisted

Mail address: Editorial Office of Journal of Clinical Hepatology, 519 Dongminzhu Street, Changchun, Jilin, China Postal code: 130061 Tel:+86-431-88782542/3542
Journal of Clinical Hepatology Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号